TH97953B - Fat metabolism enhancer - Google Patents
Fat metabolism enhancerInfo
- Publication number
- TH97953B TH97953B TH701004165A TH0701004165A TH97953B TH 97953 B TH97953 B TH 97953B TH 701004165 A TH701004165 A TH 701004165A TH 0701004165 A TH0701004165 A TH 0701004165A TH 97953 B TH97953 B TH 97953B
- Authority
- TH
- Thailand
- Prior art keywords
- genus bacillus
- bacillus
- bacteria
- bacillus subtilis
- blood
- Prior art date
Links
- 230000036740 Metabolism Effects 0.000 title 1
- 239000003623 enhancer Substances 0.000 title 1
- 230000002708 enhancing Effects 0.000 title 1
- 230000004060 metabolic process Effects 0.000 title 1
- 230000035786 metabolism Effects 0.000 title 1
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract 6
- 230000002503 metabolic Effects 0.000 claims abstract 5
- 239000003607 modifier Substances 0.000 claims abstract 5
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract 4
- 240000008371 Bacillus subtilis Species 0.000 claims abstract 4
- 229940075615 Bacillus subtilis Drugs 0.000 claims abstract 4
- 241000894006 Bacteria Species 0.000 claims abstract 4
- 210000004369 Blood Anatomy 0.000 claims abstract 4
- 239000008280 blood Substances 0.000 claims abstract 4
- 150000003626 triacylglycerols Chemical class 0.000 claims abstract 4
- 230000001580 bacterial Effects 0.000 claims abstract 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 abstract 2
- 239000003638 reducing agent Substances 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drugs Drugs 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
Abstract
การประดิษฐ์นี้นำเสนอยาและอาหารที่ไม่มีผลข้างเคียงและบริโภคต่อเนื่องได้ง่าย ซึ่งมีฤทธิ์ลด ไตรกลีเซไรด์ในเลือด กล่าวคือสารปรับปรุงเมทาบอลิสมไขมันและสารลดไตรกลีเซไรด์ในเลือดที่มีสาร ที่ได้จากการเลี้ยงแบคทีเรียในจีนัสบาซิลลัสได้ถูกเปิดเผย ยิ่งเหมาะสมขึ้น หากแบคทีเรียในจีนัส บาซิลลัสเป็นบาซิลลัส ซับติลิส และยิ่งเหมาะสมยิ่งขึ้นหากเป็นบาซิลลัส ซับติลิส C-3102 (FEPM BP- 1096) สารปรับปรุงเมทาบอลิสมไขมันและสารลดไตรกลีเซไรด์ในเลือดของการประดิษฐ์นี้ มีประโยชน์ ในการรักษาและป้องกันอาการของโรคต่างๆ เช่น โรคหลอดเลือดแข็ง เป็นต้น The invention offers drugs and food that have no side effects and are easy to consume. Reducing Triglycerides in the blood That is, lipid metabolic modifier and blood triglyceride reducer containing Obtained from bacterial culture in genus bacillus have been revealed. More appropriate If the bacteria in the genus Bacillus is a bacillus subtilis, and is even more appropriate if it is bacillus subtilis C-3102 (FEPM BP-1096), lipid metabolic modifier and blood triglyceride reducer of this invention. It is useful in treating and preventing symptoms of diseases such as arteriosclerosis, etc.
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH97953B true TH97953B (en) | 2009-08-27 |
TH97953A TH97953A (en) | 2009-08-27 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shen et al. | In vitro and in vivo antioxidant activity of Bifidobacterium animalis 01 isolated from centenarians | |
NO20075009L (en) | Nutritional supplement for HIV patients | |
CO6341563A2 (en) | ORGANIC COMPOUNDS | |
EP2241196A3 (en) | Nutritional supplement comprising oligosaccharides and cysteine for treating hiv | |
MX2008014265A (en) | Structured lipid compositions and methods of formulation thereof. | |
EA201071206A1 (en) | COMPOSITIONS CONTAINING LIPID, AND METHODS OF THEIR APPLICATION | |
NO20063410L (en) | Probiotic tablet formulations | |
DK1455603T3 (en) | Stimulation of in vivo production of proteins with a formulation comprising leucine | |
BRPI0513082A (en) | fenofibrate formulations and related treatment methods | |
EP2074985A3 (en) | Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method thereof | |
UA88165C2 (en) | Use of trisubstituted benzopyranones | |
WO2007053815A3 (en) | Compositions and methods for organic juice based skin care products | |
Makalao et al. | Composition nutritionnelle de 10 fruits sauvages consommés dans trois départements du Tchad | |
ATE460935T1 (en) | PARTICULARLY USEFUL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF METABOLIC SYNDROME | |
Samad | Rice bran oil prevents neuroleptic-induced extrapyramidal symptoms in rats: Possible antioxidant mechanisms | |
CR8265A (en) | MILK FRACTIONS AND MILK PREPARATIONS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES MEDIATED BY COX-2 | |
WO2008074935A3 (en) | Biologically active compositions, methods for producing the same and biological applications | |
WO2007101066A3 (en) | Methods and compositions for improving cardiovascular risk factors and metabolic risk factors that cause syndrome x | |
IT1315252B1 (en) | GASTRORESISTANT TABLETS FOR FOOD OR DIET USE, OBTAINED THROUGH GROUND MIXED FATS | |
BRPI0715740A8 (en) | SERUM TRIGLYCERIDE LOWERING AGENT | |
TH97953B (en) | Fat metabolism enhancer | |
TH97953A (en) | Fat metabolism enhancer | |
Carillon et al. | Dietary supplementation with a specific melon concentrate reverses vascular dysfunction induced by cafeteria diet | |
UA94434C2 (en) | Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts | |
Taechowisan et al. | In vitro anti-inflammatory activity of 4-arylcoumarins from endophytic Streptomyces aureofaciens CMUAc130 in murine macrophage RAW 264.7 cells |